Position in REGN
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$277,475
-$142,068 QoQ
Shares Held
445
-18.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#962
of 1,322 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EVERPAR ADVISORS LLC holds $767,250 across 2 Biotechnology names. REGN ranks #2 (36.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
986 | $489,775 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
445 | $277,475 |
All Filings in REGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,475 | 445 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $419,543 | 543 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $389,794 | 505 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $346,920 | 617 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $271,425 | 517 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $282,866 | 446 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $341,918 | 480 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $623,385 | 593 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $863,946 | 822 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $663,155 | 689 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $781,678 | 890 | Shares | Sole | 2024-02-06 | |
| No filing history on record for this holder in this stock. | ||||||